News 2020
European Research Council : new ERC grant for Pr. Cédric Blanpain
31/03/2020

For the third time, Pr. Cédric Blanpain – WELBIO investigator at the Université libre de Bruxelles - has obtained a grant from the European Research Council (ERC). This new project called “TrackingTumorStates” aims to define at the single cell resolution, the mechanisms regulating tumor transition states, responsible for tumor growth, differentiation, invasion, metastasis and resistance to therapy.


RNF113A protein as a new target for the treatment of lung tumours
12/03/2020

Lung cancer remains very challenging to treat, at least because of intrinsic or acquired resistance of lung cancer cells to some targeted therapies. Combinatory approches are needed to circumvent both types of resistance and new therapeutic targets are consequently needed. A study by Prof. Alain Chariot (WELBIO investigator at the GIGA, Liège) and his team consisted in defining the RNF113A protein as a new target for the treatment of lung tumours. This study has been published in Nature Communications.



Last update : 21/1/2015 - Vie privée - Printable version -  © 2020 WELBIO

Home Login